Evidence map›Paper›PMID 29801697›Full record

ArticleAcademic radiology2019

3D Printed Antibiotic and Chemotherapeutic Eluting Catheters for Potential Use in Interventional Radiology: In Vitro Proof of Concept Study.

Jeffery A Weisman, David H Ballard, Udayabhanu Jammalamadaka, Karthik Tappa, Jan Sumerel, Horacio B D'Agostino, David K Mills, Pamela K Woodard

Abstract read
In one paragraph

Article in Academic radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Development of drug loaded cardiovascular prosthesis for thrombosis prevention using 3D printing.Materials science & engineering. C, Materials for biological applications · 2021
    Article
  15. Review
  16. 3D Printing Applications for Radiology: An Overview.The Indian journal of radiology & imaging · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeffery A WeismanDepartment of Anesthesiology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110.
David H BallardMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri. Electronic address: davidballard@wustl.edu.
Udayabhanu JammalamadakaMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Karthik TappaMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Jan SumerelBASF, Florham Park, New Jersey.
Horacio B D'AgostinoDepartment of Radiology, Louisiana State University Health Shreveport, Shreveport.
David K MillsDepartment of Biomedical Engineering, Louisiana Tech University, Ruston, Louisiana.
Pamela K WoodardMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Funding

Training OPportunities in Translational Imaging Education and Research (TOP-TIER)T32EB021955 · NIBIB · WASHINGTON UNIVERSITY · PI Hongyu An, Joseph Edward Ippolito · 2017 to 2026
$2.4M
NIBIB NIH HHS T32 EB021955
6 · The paper itself

Abstract

RATIONALE AND

objectivesAdditive manufacturing may be used as a form of personalized medicine in interventional radiology by allowing for the creation of customized bioactive constructs such as catheters that can act as a form of localized drug delivery. The purpose of the present in vitro study was to use three-dimensional (3D) printing to construct bioactive-laden bioabsorbable catheters impregnated with antibiotics and chemotherapeutics. MATERIALS AND

methodsPolylactic acid bioplastic pellets were coated with the powdered bioactive compounds gentamicin sulfate (GS) or methotrexate (MTX) to incorporate these drugs into the 3D printed constructs. The pellets were then extruded into drug-impregnated filament for fused deposition modeling 3D printing. Computer-aided design files were generated in the shapes of 14-F catheters. Scanning electron microscope imaging was used to visualize the presence of the additive powders on the surface of the printed constructs. Elution profiles were run on the antibiotic-laden catheter and MTX-laden catheters. Antibiotic-laden catheters were tested on bacterial broth and plate cultures.

resultsBoth GS and MTX catheter constructs had sustained drug release up to the 5-day limit of testing. The 3D printed GS-enhanced catheters inhibited all bacterial growth in broth cultures and had an average zone of inhibition of 858 ± 118 mm

conclusionThe 3D printing manufacturing method to create instruments in percutaneous procedures is feasible. Further in vivo studies will substantiate these findings.

Indexed as

CathetersDrug Delivery SystemsPrinting, Three-DimensionalRadiology, InterventionalAbsorbable ImplantsAnti-Bacterial AgentsAntimetabolites, AntineoplasticCoated Materials, BiocompatibleHumansMethotrexatePolyestersProof of Concept StudyAnti-Bacterial AgentsAntimetabolites, AntineoplasticCoated Materials, BiocompatibleMethotrexatePolyesterspoly(lactide)3D printingadditive manufacturingcatheterinterventional radiologypersonalized medicinethree-dimensional printing

Identifiers

PMID29801697
PMCPMC6488040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.